Allied Corp has signed a 5-year forward purchase agreement with Polish distributor Canpoland. The total contract value is estimated at EUR 15.3 million over 5 years.
Under this supply agreement, Allied will deliver 1,05 Tons of premium Colombian-grown cannabis flower annually to Poland through Blossom Genetics, its EU-GMP processing and manufacturing partner in Portugal. The deal includes the launch of three proprietary genetics, each contributing 350kg per year supported by minimum quarterly orders to meet the demand for medical-grade cannabis in Poland.
Michael Moses, commented on the agreement: "This partnership is a testament to Allied's commitment to quality and regulatory compliance, as well as our focus to scaling our operations in Europe. Canpoland's position in Poland aligns perfectly with our mission to bring premium medical-grade cannabis to new markets."
The Polish medical market is notoriously complex to enter, with significant administrative hurdles for registration and approvals from the governing entities which can take up to a year. Juba Hadid commented "The high regulatory barriers to entry into Poland hide a demand-driven market which in itself represents a unique opportunity to become a leader in the Polish market". Pending the approval from the authorities on the registration dossier, Allied expects to land its first shipment in the third Quarter of 2025.
For more information:
Allied Corp
allied.health